Vicore Pharma
1 known investors
Vicore Pharma is a clinical-stage biopharmaceutical company developing treatments for diseases in which the AT2 (angiotensin II type 2) receptor plays a central role. It conducts preclinical and clinical research across multiple indications targeting AT2 receptor biology.